BASIC CHARACTERISTICS OF SPECIFIC TRIIDOTHYRONINE BINDING WITH CELL-TARGETS OF PATIENTS WITH THYROID CARSINOMA DURING TREATMENT
Abstract
The parameters of specific triidothyronine binding with lymphocytes of patients operated for highly differentiated thyroid cancer and received comprehensive treatment, on the average, for 15 years are studied. These patients have revealed a significant increase of interaction affinity and a decrease in the number of binding places in comparison with these characteristics of the persons of the control group. A relationship of the studied indices between the factors of treatment and its duration is shown. Patients with overweight have revealed a significant increase in interaction affinity and a decrease in the number of binding places as compared to patients with normal weight, which explains a decreased need in triiodothyronine in this group of patients.
About the Authors
T. A. MITYUKOVABelarus
Т. А. LEONOVA
Belarus
S. V. MANKOVSKAYA
Belarus
О. V. SVIRIDOV
Belarus
References
1. Демидчик, Е. П. Рак щитовидной железы у детей (последствия аварии на Чернобыльской АЭС) / Е. П. Демидчик, А. Ф. Цыб, Е. Ф. Лушников. – М., 1996.
2. Oppenheimer J. H. [et al.] // J. Clin. Endocrinol. Metabol. – 1991. – Vol. 73. – P. 990–994.
3. Samuels, H. H., Tsai J. S. // Proc. Natl. Acad. Sci USA. – 1973. – Vol. 70. – P. 3488–3492.
4. Elewaut, A. Triiodthyronine binding to lymphocyte nuclei and plasma cyclic AMP response to intravenous glucagons in patients with peripheral resistance to thyroid hormones / A. Elewaut, M. de Baets, A. Vermeulen // Acta endocrinol. – 1981. – Vol. 97. – P. 54–59.
5. Human lymphocyte binding and deiodination of thyroid hormones in relation to thyroid function / A.-C. Holm [et al.] // Acta Endocrinol. – 1975. – Vol. 80. – P. 642–656.
6. A case of hypersensitivity to thyroid hormones with normally functioning thyroid gland and increased nuclear triiodotyronine receptors / C. Jaffiol [et al.] // J. Endocrinol. Invest. – 1990. – Vol. 13. – P. 839–845.
7. Liewendahl, K. Nuclear binding of triiodothyroine and thyroxine in lymphocytes from subjects with hyperthyroidism, hypothyroidism and resistance to thyroid hormones / K. Liewendahl, S. Rosengard, B.-A. Lamberg // Clin. Chim. Acta. – 1978. – Vol. 83. – P. 41–48.
8. Лебедев, К. А. Иммунограмма в клинической практике / К. А. Лебедев, И. Д. Понякина. – М., 1990.
9. Специфическое связывание трийодтиронина с лимфоцитами у пациентов, прооперированных по поводу карциномы щитовидной железы / Т. А. Митюкова [и др.] // Весцi НАН Беларусi. Сер. мед. навук. – 2009. – № 2. – С. 55–62.
10. Платонова, Т. Ю. «Компьютерная программа для расчета параметров специфического связывания на основе Скэтчардовских кривых» / Т. Ю. Платонова, М. В. Платонов, Т. А. Митюкова; РНПЦ МТ. – инв. № 000194, B.R., дата регистрации 24.11.2008 г.
11. Оценка индивидуальной чувствительности к тироксинотерапии / Т. А. Митюкова [и др.] // Весцi НАН Беларусi. Сер. мед. навук. – 2014. – № 2. – C. 81–89.
12. Федорович, Е. И. Биомедицинские аспекты взаимодействия тиреоидных гормонов с эритроцитами при раке щитовидной железы / Е. И. Федорович, Ю. Е. Демидчик, О. В. Свиридов. – М., 2001.